Kalaris Therapeutics (KLRS) Change in Interest Receivables (2019 - 2024)
Kalaris Therapeutics (KLRS) reported Change in Interest Receivables of -$53,000 for Q4 2024, compared with -$28,000 a year earlier.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Change in Interest Receivables (2019 - 2024) Analysis & Trends
For FY2024, Kalaris Therapeutics posted Change in Interest Receivables of -$206,000.
- By year, Change in Interest Receivables came in at $49,000 in FY2023 (-54.2%), $107,000 in FY2022, -$400,000 in FY2021 and $188,000 in FY2020 (-28.2%).
- Five-year quarterly Change in Interest Receivables spans a low of -$258,000 in Q3 2021 and a high of $364,000 in Q3 2020.
- Per Business Quant data, the three quarters before Q4 2024 came in at -$43,000 (Q3 2024), -$84,000 (Q2 2024) and -$26,000 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Kalaris Therapeutics | 68.80 Mn | 68.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -53,000.00 |
| Sep 30, 2024 | -43,000.00 |
| Jun 30, 2024 | -84,000.00 |
| Mar 31, 2024 | -26,000.00 |
| Dec 31, 2023 | -28,000.00 |
| Sep 30, 2023 | 128,000.00 |
| Jun 30, 2023 | -138,000.00 |
| Mar 31, 2023 | 87,000.00 |
| Dec 31, 2022 | -104,000.00 |
| Sep 30, 2022 | 170,000.00 |
| Jun 30, 2022 | -81,000.00 |
| Mar 31, 2022 | 122,000.00 |
| Dec 31, 2021 | -101,000.00 |
| Sep 30, 2021 | -258,000.00 |
| Jun 30, 2021 | -60,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Dec 31, 2020 | 28,000.00 |
| Sep 30, 2020 | 364,000.00 |
| Jun 30, 2020 | -253,000.00 |
| Mar 31, 2020 | 49,000.00 |
API Access
Kalaris Therapeutics Change in Interest Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-interest-receivables&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-interest-receivables", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-interest-receivables&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();